Hehe.
Look how well that turned out for the USSR.
On the subject of morals, you're absolutely right. Morality prevents us from killing the less productive in society to reduce their burden. It prevents us from allowing the rich to rule over the poor in a feudal system. But morality is subjective enough that what you consider unthinkable, another considers acceptable. It's fair to say that having fewer moral issues with sacrificing things like environmental health will equal greater profits for businesses which influence it. The same could also be said for the ethical treatment of animals. Or the running of sweatshops. Point is, you could refuse to buy these products or work for a business that employs them. Flipside is that most people don't care. They'd rather have money than morals.
Good luck paying the bills with morals.
So we get drugs cheaper due to our non-capitalist system?
Works for me.
They still have high enough prices to make a profit, clearly (or they wouldn't sell drugs here at all) so what's the problem? In any case, Britain has a fine R&D section for drugs.
The companies market the drugs to the UK because it's still more profitable than not doing so. However what you might not realize is that your country actually doesn't subsidize the full range of drugs, only a portion that the government and industry agree upon. If the government refuses to meet the company's target, they simply don't bother. Others will be heavily restricted in who has authority to receive the drug, even though it might be helpful to patients who don't meet the criteria. This is to reduce the amount of money the government has to hand out. The process is called Pharmacoeconomics, and it's a fascinating area to work in.
As for having a fine pharmaceutical R&D section, I have one word for you: Pfizer.
In terms of TV advertising, that falls within freedom of speech. A company shouldn't be silenced from letting people know about their product, even if the choice to prescribe it must come from a doctor. Many countries disagree with this and regulate drug advertising to greater or lesser degrees.